Absci Ownership | Who Owns Absci?
Absci Ownership Summary
Absci is owned by 99.78% institutional investors, 11.85% insiders. Fmr is the largest institutional shareholder, holding 16.61% of ABSI shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.66% of its assets in Absci shares.
ABSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Absci | 99.78% | 11.85% | -11.63% |
| Sector | Healthcare Stocks | 50.53% | 12.40% | 37.07% |
| Industry | Biotech Stocks | 48.96% | 12.12% | 38.92% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 25.41M | 16.61% | $294.50M |
| Ark investment management | 12.93M | 8.45% | $149.80M |
| Blackrock funding, inc. /de | 12.18M | 7.96% | $141.11M |
| Vanguard group | 7.91M | 5.50% | $27.61M |
| Blackrock | 5.34M | 5.38% | $16.46M |
| State street | 8.10M | 5.29% | $93.85M |
| Ameriprise financial | 6.99M | 4.57% | $81.03M |
| Redmile group | 6.74M | 4.41% | $78.11M |
| Vanguard capital management | 6.12M | 4.00% | $70.96M |
| Advanced micro devices | 5.71M | 3.74% | $66.23M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gem investment advisors | 2.17M | 15.43% | $25.16M |
| Redmile group | 6.74M | 5.24% | $78.11M |
| Advanced micro devices | 5.71M | 5.05% | $66.23M |
| Scientech research | 124.43K | 1.17% | $1.44M |
| Parkman healthcare partners | 894.37K | 1.06% | $10.37M |
| Great point partners | 796.44K | 1.00% | $2.42M |
| Artia global partners lp | 464.44K | 0.99% | $5.38M |
| Ark investment management | 12.93M | 0.97% | $149.80M |
| Bvf inc/il | 2.36M | 0.70% | $27.37M |
| Platinum investment management | 237.76K | 0.68% | $2.76M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 5.70M | 0.09% | 5.70M |
| D. e. shaw | 5.24M | 0.03% | 4.59M |
| Blackrock | 5.34M | 0.00% | 4.45M |
| Ameriprise financial | 6.99M | 0.02% | 3.81M |
| Fmr | 25.41M | 0.01% | 2.86M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Massachusetts financial services co /ma/ | - | - | -1.72M |
| Redmile group | 6.74M | 5.24% | -1.51M |
| Laurion capital management lp | - | - | -1.19M |
| Heights capital management | - | - | -1.07M |
| Affinity asset advisors | - | - | -1.02M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 5.70M | 0.09% | 5.70M | $66.12M |
| Bvf inc/il | 2.36M | 0.70% | 2.36M | $27.37M |
| Voloridge investment management | 1.60M | 0.08% | 1.60M | $18.58M |
| Sixth street partners management company | 1.17M | 0.00% | 1.17M | $13.51M |
| Integral health asset management | 800.00K | 0.37% | 800.00K | $9.27M |
Sold Out
| Holder | Change |
|---|---|
| Pineridge advisors | -1.00 |
| Capital performance advisors llp | -11.00 |
| Ifp advisors | -63.00 |
| Twin peaks wealth advisors | -69.00 |
| Riggs asset managment | -78.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 205 | 19.88% | 152,630,528 | 20.94% | 99 | 1.17% | 128 | 36.17% | 48 | 20.00% |
| Mar 31, 2026 | 133 | -10.74% | 88,914,683 | -27.17% | 65 | 0.90% | 73 | - | 30 | -9.09% |
| Dec 31, 2025 | 40 | -73.15% | 14,828,343 | -84.67% | 10 | 0.18% | 16 | -80.00% | 7 | -79.41% |
| Sep 30, 2025 | 52 | -61.48% | 14,647,739 | -83.64% | 11 | 0.23% | 24 | -67.12% | 8 | -76.47% |
| Jun 30, 2025 | 134 | -8.22% | 89,499,197 | 4.64% | 70 | 1.49% | 72 | -14.29% | 34 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 11.29M | 6.66% | 924.20K |
| ARK Genomic Revolution | 10.23M | 6.04% | -973.52K |
| ARK Genomic Revolution ETF | 10.29M | 5.99% | -216.72K |
| Fidelity Growth Compy Commingled Pl O | 5.75M | 5.06% | - |
| Fidelity Growth Company Fund | 7.90M | 4.67% | 690.02K |
| State Street® SPDR® S&P® Biotech ETF | 5.09M | 3.01% | 11.69K |
| Vanguard Total Stock Mkt Idx Inv | 4.41M | 2.60% | 154.10K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.41M | 2.60% | 154.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.46M | 2.60% | 55.06K |
| iShares Russell 2000 ETF | 3.51M | 2.07% | -62.30K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Szela Mary T | - | Buy | $148.87K |
| May 13, 2026 | Pangalos Menelas N | - | Buy | $200.75K |
| Mar 12, 2026 | Busch Andreas | Chief Innovation Officer | Buy | $229.00K |
| Feb 27, 2026 | Pangalos Menelas N | - | Buy | $205.76K |
| Feb 02, 2026 | McClain Sean | Chief Executive Officer | Sell | $80.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | - |
| 2026 Q1 | 2 | 2 |
| 2025 Q4 | 1 | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | - |
ABSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools